REORDEX Trademark

Trademark Overview

On Tuesday, January 27, 2009, a trademark application was filed for REORDEX with the United States Patent and Trademark Office. The USPTO has given the REORDEX trademark a serial number of 77657684. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, March 10, 2009. This trademark is owned by Pfizer Inc.. The REORDEX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
reordex

General Information

Serial Number77657684
Word MarkREORDEX
Filing DateTuesday, January 27, 2009
Status601 - ABANDONED - EXPRESS
Status DateTuesday, March 10, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 30, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, March 10, 2009ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Tuesday, March 10, 2009ABANDONMENT - EXPRESS MAILED
Monday, March 9, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Friday, January 30, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 30, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

reordex preparations pharmaceutical disease treatment dysfunction vaccines human sexual obesity disorders